Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize

Tumour resistance to radiotherapy remains a barrier to improving cancer patient outcomes. To overcome radioresistance, certain drugs have been found to sensitize cells to ionizing radiation (IR). In theory, more potent radiosensitizing drugs should increase tumour kill and improve patient outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Stephen R., Yang, Howard C., Savariar, Elamprakash N., Aguilera, Joe, Crisp, Jessica L., Jones, Karra A., Whitney, Michael A., Lippman, Scott M., Cohen, Ezra E. W., Tsien, Roger Y., Advani, Sunil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059467/
https://www.ncbi.nlm.nih.gov/pubmed/27698471
http://dx.doi.org/10.1038/ncomms13019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059467/
https://www.ncbi.nlm.nih.gov/pubmed/27698471
http://dx.doi.org/10.1038/ncomms13019

Ejemplares similares